Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Alvotech fundraises $300m to bolster biosimilar development

Alvotech raised $300m through a private bond offering and is set to use the earnings to continue the growth of its biosimilar pipeline.

Celgene licenses immuno-oncology pipeline in $80m deal

Celgene and Kyn Therapeutics enter a licensing agreement to develop Kyn’s immuno-oncology pipeline for investigative therapies after Celgene was acquired by BMS.

GenScript simplifies antibody purification process

Gene synthesis provider, GenScript, launched its new purification instrument, AmMag SA, to simplify purification processes and reduce time invested.

Sanofi licenses bi- and multi-specific antibody platform

Sanofi entered an agreement for the discovery and development of antibodies via Biomunex antibody platform.

Boehringer expands commercial biologics production capacity in China

Boehringer will increase its capacity for commercial manufacturing of biologics at its Shanghai, China, facility.

Global Industry News

Hot Topics

Spotlight

Hired and Retired: High profile exits to biotech

Pfizer cuts five biosimilar candidates and 150 jobs in R&D shakeup

Sanofi invests €80m and extends collaboration agreement with BioNTech

Samsung Bioepis partner brings biosimilars to China

‘A relatively small footprint’: Drug delivery for biologics to the brain

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics